MoldvayJ,StrauszJ,EgervaryM,et al.p53 expression in stageI squamous cell lung cancer. Pathology and Oncology Research . 1998Moldvay J, Strausz J, Egervary M, Agocs L, Bocsi J, Schaff Z: P53 expression in stage I squamous cell lung cancer. Pathol Oncol Res 1998, 4:8-13....
Lu, S. et al. Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial.Lancet R...
cancer [22];MYOD1in hematological neoplasm;APC,HOX2,OTX1genes in non-small cell lung carcinoma (NSCLC) [24]; FEN1 in breast tumor cells [25]; and hypomethylation of TKTL1 in head and neck squamous cell carcinoma [26]. Literature provides evidence correlating transcriptional activities with m...
Afatinib, an irreversible ErbB-family blocker, could improve the survival of advanced epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer patients (NSCLCm+). This phase II trial (NCT04201756) aimed to assess the feasibility of neoad
Stereotactic body radiation therapy (SBRT) versus surgery for operable early-stage non-small cell lung cancer (ES-NSCLC) remains highly debated. Herein, we used spatial proteomics to identify whether any molecular biomarker(s) associate with the efficacy of either modality, in efforts to optimize ...
PURPOSE Stage I non-small cell lung cancer (NSCLC) can be treated with surgery or stereotactic ablative radiotherapy (SABR) and predictors of treatment failure may enable selection of patients for adjuvant treatment. Glycolytic metabolism, as assessed by SUVmax in 18F-fluorodeoxyglucose PET, glucose ...
Nivolumab Plus Ipilimumab vs Nivolumab for Patients With Stage IV Squamous Cell Lung Cancer View LargeDownload Figure 1. CONSORT Diagram View LargeDownload Figure 2. Kaplan-Meier Curves for Overall Survival and Progression-Free Survival View LargeDownload A, Overall survival for nivolumab vs nivolumab ...
Histological diagnosis of the explanted lung revealed adenocarcinoma in six, squamous cell carcinoma in three, and lepidic predominant adenocarcinoma in two cases, respectively. Staging revealed stage IA (pT1a/b pN0) in eight and IB (pT2a pN0) in two cases and one patient in stage IIA (p...
Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revision for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry. J Thorac Oncol 2007;2:1078–1085. 25 Sidhu SG, Wieczorek R, Cassai ND, et...
cell carcinoma), and 45 patients with benign lung diseases (including pneumonia, hamartoma, pulmonary tuberculosis, granuloma, and others). All patients were diagnosed by a panel of pathologists together and the tumours staged according to the international standards for TNM staging of lung cancer. ...